[Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
D001224:Aspartic Acid / Q000627:therapeutic use*; D001803:Blood Transfusion; D005260:Female; D006505:Hepatitis / Q000188:drug therapy*; D006509:Hepatitis B; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D009952:Ornithine / Q000627:therapeutic use*; D014376:Tuberculosis / Q000150:complications*
D001224:Aspartic Acid; D009952:Ornithine; D007538:Isoniazid